Biogen trembled the crowd by announcing a new pharmaceutical drug, which is becoming the first line of treatment to slow down Alzheimer’s disease progression.
Biogen trembled the crowd by announcing a new pharmaceutical drug, which is becoming the first line of treatment to slow down Alzheimer’s disease progression.